Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Akrimax Enters Manufacturing Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Akrimax Enters Manufacturing Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Akrimax Pharmaceuticals has entered a manufacturing agreement for the production of pharmaceutical products for an undisclosed global company. Akrimax will begin production in 2009. 
    
Akrimax president Alan L. Rubino commented, “This agreement further validates Akrimax’s decision to acquire the [Wyeth] Rouses Point facility, which possesses diverse manufacturing and packaging capabilities, and a spotless regulatory and safety record. We are pleased to announce this development as we are ahead of our planned schedule of bringing in new manufacturing partnerships to our Rouses Point facility.”

Akrimax is a specialty pharma company focusing on metabolic syndrome treatments. The company also has a contract manufacturing division.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters